Here we show that oral administration of the non-calorie sweetener, rare sugar d-allulose (d-psicose), induces GLP-1 release, activates vagal afferent signaling, reduces food intake and promotes glucose tolerance in healthy and obese-diabetic animal models
Here are the latest snow totals reported to the National Weather Service as of Sunday morning
GLP-1 agonists are known to slow down gastric emptying (thats part of how they make you feel full)
Treatment for Type 2 Diabetes: It helps lower blood sugar by increasing insulin release when glucose is high
Individual results depend on dose, adherence, side effects, diet, activity, sleep, stress, medical history and follow up